Jump to content
RemedySpot.com

Novel Ad-ISF35 immune therapy explained

Rate this topic


Guest guest

Recommended Posts

Guest guest

Novel Ad-ISF35 immune therapy for CLL explained

http://bcrfund.net/news/story_cllvaccine.html

Infection by a modified cold virus Ad-ISF35 is thought to induce innate

immunity against the infected abnormal lymphocytes. Ad-ISF35 is also

thought to reactivate genes that restore sensitivity to chemotherapy.

Clinical trial http://clinicaltrials.gov/ct2/show/NCT00942409 for CLL and

NHL

Karl Schwartz

www.Lymphomation.org

Evidence-based information on lymphoma, independent of health industry

funding

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...